cell carcinoma. The prognostic significance of the loss of ARID1A expression is not known.
The current study was designed to evaluate whether ARID1A was a prognostic factor for
progression, survival, and chemoresistance in ovarian clear cell carcinoma. A total of 60
patients, who were surgically treated for primary ovarian clear cell adenocarcinoma, were
enrolled. Surgical specimens were examined for ARID1A protein expression by …